Molecular genetic insights into cardiovascular disease

Science
M Keating, M C Sanguinetti

Abstract

The recent application of molecular genetic tools to inherited forms of cardiovascular disease has provided important insight into the molecular mechanisms underlying cardiac arrhythmias, cardiomyopathies, and vascular diseases. These studies point to defects in ion channels, contractile proteins, structural proteins, and signaling molecules as key players in disease pathogenesis. Genetic testing is now available for a subset of inherited cardiovascular diseases, and new mechanism-based therapies may be available in the near future. This remarkable progress and the implications it may have for more common forms of cardiovascular disease are reviewed here.

References

Sep 17, 1992·The New England Journal of Medicine·G M VincentM Keating
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·F TaroniS DiDonato
Jul 25, 1991·Nature·C L MaslenL Y Sakai
Nov 1, 1991·The Journal of Clinical Investigation·H KuivaniemiD J Prockop
Dec 26, 1991·The New England Journal of Medicine·G HugS Soukup
Nov 1, 1990·The Journal of Clinical Investigation·S KontusaariD J Prockop
Aug 10, 1989·The New England Journal of Medicine·UNKNOWN Cardiac Arrhythmia Suppression Trial (CAST) Investigators
Aug 24, 1995·Nature·P B BennettA L George
Oct 5, 1995·The New England Journal of Medicine·A E GuttmacherR I White
Jan 15, 1995·Circulation·M Dammerman, J L Breslow
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A K EwartM Keating
Jan 15, 1996·The Journal of Clinical Investigation·T M Olson, M T Keating
Apr 1, 1996·Nature Genetics·S BioneD Toniolo
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·M C SanguinettiM T Keating

❮ Previous
Next ❯

Citations

Feb 13, 2001·The Journal of Experimental Zoology·E JohnsonH Dowse
May 15, 2010·Cardiovascular Toxicology·Bernd J Zünkler, Maria Wos-Maganga
Apr 15, 2004·Bioorganic & Medicinal Chemistry·Alex M Aronov, Brian B Goldman
Feb 28, 2002·AIDS Treatment News
Mar 14, 2002·European Journal of Pharmacology·Delphine S DupuisSøren P Olesen
Apr 13, 2000·Pharmacology & Therapeutics·K Nakagawa, T Ishizaki
May 8, 2001·Trends in Pharmacological Sciences·J I VandenbergT J Campbell
Jan 1, 1997·Trends in Pharmacological Sciences·A E Busch, H Suessbrich
Aug 12, 1999·Free Radical Biology & Medicine·C CsonkaA Tosaki
Jan 16, 1999·Current Opinion in Biotechnology·M E Curran
May 1, 1997·Trends in Cardiovascular Medicine·A M Brown
Feb 13, 2003·Drug Discovery Today·Robert F Gilmour
Jul 20, 2006·Quarterly Reviews of Biophysics·Yoram Rudy, Jonathan R Silva
Dec 6, 2002·British Journal of Pharmacology·Teresa GonzálezCarmen Valenzuela
Jan 1, 1998·The New England Journal of Medicine·A A Grace, A J Camm
Jan 22, 2010·The Journal of Biological Chemistry·Hai M Nguyen, Alan L Goldin
Dec 20, 2005·The Journal of Biological Chemistry·Qiuming GongZhengfeng Zhou
Jun 6, 2000·The Journal of Infectious Diseases·J M Penninger, K Bachmaier
Apr 9, 2001·Antioxidants & Redox Signaling·T PatakiA Tosaki
Aug 5, 2008·Tissue Engineering. Part a·Carlota Diaz Sanchez-BustamanteMartin Fussenegger
Jan 15, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Anne Friemel, Bernd J Zünkler
Aug 6, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·H GutgesellK A Taubert
Apr 24, 2001·Current Opinion in Pediatrics·D Bockenhauer
Jan 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J M PenningerK Bachmaier
Dec 18, 2001·The Journal of Physiology·Y LuJ I Vandenberg
Jan 8, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Jochen RoseGordon F Tomaselli
Oct 25, 2000·Circulation·J E BurnesY Rudy
Nov 7, 1998·Clinical Chemistry and Laboratory Medicine : CCLM·C P Pang
Apr 3, 2012·Pharmacogenomics·David Della-MorteTatjana Rundek
Nov 10, 2000·Biochemical and Biophysical Research Communications·K R WongJ I Vandenberg
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·C L WelchA R Tall
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·F SestiS A Goldstein
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·J S MitchesonM C Sanguinetti
Apr 28, 2010·Nature Reviews. Cardiology·Sumeet S Chugh
Jul 1, 1999·The Journal of Cardiovascular Nursing·V M Vizgirda
Mar 5, 2004·Expert Opinion on Therapeutic Targets·Robert F Gilmour
Nov 21, 2009·Expert Opinion on Pharmacotherapy·Antonia M R BilleciValeria Caso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.